Search by Drug Name or NDC

    NDC 00469-1230-50 Prograf 0.2 mg/1 Details

    Prograf 0.2 mg/1

    Prograf is a ORAL GRANULE, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Astellas Pharma US, Inc.. The primary component is TACROLIMUS.

    Product Information

    NDC 00469-1230
    Product ID 0469-1230_32e10bd8-7464-4967-bdc5-1a5ee660bfb3
    Associated GPIs 99404080003010
    GCN Sequence Number 066071
    GCN Sequence Number Description tacrolimus GRAN PACK 0.2 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 28251
    HICL Sequence Number 020974
    HICL Sequence Number Description TACROLIMUS
    Brand/Generic Brand
    Proprietary Name Prograf
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tacrolimus
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GRANULE, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 0.2
    Active Ingredient Units mg/1
    Substance Name TACROLIMUS
    Labeler Name Astellas Pharma US, Inc.
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA210115
    Listing Certified Through 2024-12-31

    Package

    NDC 00469-1230-50 (00469123050)

    NDC Package Code 0469-1230-50
    Billing NDC 00469123050
    Package 50 PACKET in 1 CARTON (0469-1230-50) / 1 GRANULE, FOR SUSPENSION in 1 PACKET
    Marketing Start Date 2018-05-24
    NDC Exclude Flag N
    Pricing Information N/A